Peter Ellis
- Oncology top 0.05%
- Lung Cancer Research Studies 59
- Cancer Treatment and Pharmacology 39
- HER2/EGFR in Cancer Research 37
- Cancer Research top 0.1%
- Breast Cancer Treatment Studies 42
- Cancer Genomics and Diagnostics 32
- Pulmonary and Respiratory Medicine top 0.1%
- Lung Cancer Treatments and Mutations 93
- Lung Cancer Diagnosis and Treatment 49
- Developmental Neuroscience top 0.5%
-
- Palliative Care and End-of-Life Issues 31
- Co-authors
- Martin H.N. TattersallPhyllis ButowLarysa PevnyVictoria GrahamJane KhudyakovMartine PiccartRebecca HagertySherene Loi
- Journals
- Journal of Clinical Oncology (66 papers)Journal of Thoracic Oncology (25 papers)Annals of Oncology (16 papers)
- Partner nations
- United KingdomCanadaUnited States
In The Last Decade
Peter Ellis
763 papers receiving 36.0k citations
Hit Papers
Peers
Comparison fields: 5 of 241
- Oncology 10.0k
- Cancer Research 5.1k
- Pulmonary and Respiratory Medicine 6.8k
- Developmental Neuroscience 676
- Applied Microbiology and Biotechnology 326
Countries citing papers authored by Peter Ellis
This map shows the geographic impact of Peter Ellis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Ellis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Ellis more than expected).
Fields of papers citing papers by Peter Ellis
This network shows the impact of papers produced by Peter Ellis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Ellis. The network helps show where Peter Ellis may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peter Ellis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 7 | |
| 5 | 2023 | 11 | |
| 6 | 2023 | 17 | |
| 7 | 2021 | 52 | |
| 8 | 2020 | 67 | |
| 9 | 2019 | 10 | |
| 10 | 2018 | 52 | |
| 11 | 2016 | 6 | |
| 12 | 2016 | 22 | |
| 13 | High burden and pervasive positive selection of somatic mutations in normal human skinbreakdown → | 2015 | 1123 |
| 14 | Payer and provider collaborations that improve quality outcomes in oncology. | 2010 | 1 |
| 15 | 2009 | 111 | |
| 16 | 2007 | 160 | |
| 17 | Predictors of response to systemic therapy in breast cancer. | 2002 | 10 |
| 18 | The natriuretic and diuretic efficacy of atriopeptidase inhibitors following intravenous and oral administration. | 1989 | 1 |
| 19 | 1979 | 17 | |
| 20 | 1973 | 45 |
About Peter Ellis
Peter Ellis is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 851 papers that have together received 37.5k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (93 papers), Lung Cancer Research Studies (59 papers), Lung Cancer Diagnosis and Treatment (49 papers), Breast Cancer Treatment Studies (42 papers), Cancer Treatment and Pharmacology (39 papers), HER2/EGFR in Cancer Research (37 papers), Cancer Genomics and Diagnostics (32 papers) and Palliative Care and End-of-Life Issues (31 papers). The work is most often cited by research in Oncology (10.0k citations), Cancer Research (5.1k citations) and Pulmonary and Respiratory Medicine (6.8k citations). Peter Ellis has collaborated with scholars based in United Kingdom, Canada and United States. Frequent co-authors include Martin H.N. Tattersall, Phyllis Butow, Larysa Pevny, Victoria Graham, Jane Khudyakov, Martine Piccart, Rebecca Hagerty, Sherene Loi, Christos Sotiriou and Natasha B. Leighl. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology, Annals of Oncology, Clinical Lung Cancer and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.